Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular gene therapy: an overview

H G Klein1

  • 1Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, Bethesda, Maryland 20892.

Journal of Clinical Apheresis
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen-reduction methods: advantages and limits.

ISBT science series·2020
Same author

Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis.

Transfusion medicine (Oxford, England)·2018
Same author

International Forum regarding practices related to donor haemoglobin and iron.

Vox sanguinis·2016
Same author

Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis.

Vox sanguinis·2016
Same author

Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

Vox sanguinis·2011
Same author

The relevance of practice misalignments to trials in transfusion medicine.

Vox sanguinis·2010
Same journal

Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee.

Journal of clinical apheresis·2026
Same journal

The Role of Therapeutic Apheresis in the Management of Rheumatoid Arthritis A Systematic Review and Meta-Analysis.

Journal of clinical apheresis·2026
Same journal

Thrombocytapheresis as a Bridge Intervention in JAK2-Mutant Myeloproliferative Neoplasm Complicated by Acquired von Willebrand Disease: A Case Report.

Journal of clinical apheresis·2026
Same journal

Plerixafor Plus G-CSF Versus Etoposide Combined With Cyclophosphamide and G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Single Center Observational Propensity Score-Matched Cohort Study.

Journal of clinical apheresis·2026
Same journal

Beyond the Centrifuge: Is FcRn Inhibition Ready to Replace Apheresis in Treatment of Guillain-Barré Syndrome?

Journal of clinical apheresis·2026
Same journal

Correction to "Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System".

Journal of clinical apheresis·2026
See all related articles

Gene therapy utilizes recombinant DNA technology for treating diseases. Early successes in correcting inherited disorders like adenosine deaminase deficiency show promise for treating cancer and AIDS.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cell Biology

Background:

  • Recombinant DNA technology enables gene-based cellular therapies.
  • Molecular characterization of diseases provides the rationale for gene therapy.
  • Advances in cell biology and gene delivery have made somatic cell gene therapy feasible.

Purpose of the Study:

  • To review the progress and potential of gene-based cellular therapies.
  • To highlight the scientific rationale and technological feasibility of gene therapy.
  • To discuss current and future applications of gene therapy for various diseases.

Main Methods:

  • Utilizing gene therapy to deliver gene products via cell-based delivery systems.
  • Employing recombinant DNA technology for gene modification of cells.

Related Experiment Videos

  • Developing and advancing cell biology, cytokine physiology, and gene delivery techniques.

    • Main Results:

    • The first human gene therapy in 1990 successfully treated severe combined immunodeficiency due to adenosine deaminase deficiency.
    • Over a dozen clinical protocols are in development, using diverse cell types and vectors.
    • Gene therapy shows potential for treating inherited genetic diseases, cancer, and AIDS.

    Conclusions:

    • Gene therapy, particularly somatic cell gene therapy, is a rapidly advancing field with significant therapeutic potential.
    • Despite challenges in gene transfer efficiency and quality assurance, practical strategies for cellular gene therapy are emerging.
    • The ability to manipulate and expand cells for therapeutic purposes offers new avenues for treating complex diseases.